US2002076779A1PendingUtilityA1
Leucine-rich repeat proteins, Zlrr7, Zlrr8 and Zlrr9
Priority: Jun 30, 2000Filed: Jul 2, 2001Published: Jun 20, 2002
Est. expiryJun 30, 2020(expired)· nominal 20-yr term from priority
C07K 2319/00C07K 14/47C07K 14/52
58
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
The present invention provides to polynucleotides and secreted Leucine-Rich Repeat proteins encoded by the polynucleotides. The proteins include binding proteins and fusion proteins operably linked to a second polypeptide. The invention further provides therapeutic and diagnostic methods utilizing the polynucleotides, polypeptides, and antagonists of the polypeptides.
Claims
exact text as granted — not AI-modifiedWe claim:
1 . An isolated polypeptide comprising residues 27 to 234 as shown in SEQ ID NO:2.
2 . The isolated polypeptide of claim 1 wherein the polypeptide further comprises residues 1 to 234 as shown in SEQ ID NO:2.
3 . An isolated polynucleotide comprising a sequence of nucleotides, wherein the sequence encodes the isolated polypeptide of claim 1 .
4 . An expression vector comprising the following operably linked elements:
a transcription promoter; a DNA segment having the isolated polynucleotide of claim 3; and a transcription terminator.
5 . A cultured cell comprising the expression vector of claim 4 .
6 . A method of producing a polypeptide comprising culturing the cell of claim 5 under conditions whereby said sequence of nucleotides is expressed, and recovering said polypeptide.
7 . A polypeptide produced by the method of claim 6 .
8 . An antibody that specifically binds to the isolated protein of claim 1 .
9 . An isolated polynucleotide comprising the polynucleotide sequence as shown in SEQ ID NO: 1.
10 . An isolated polypeptide comprising residues 16 to 279 as shown in SEQ ID NO:8.
11 . The isolated polypeptide of claim 10 wherein the polypeptide further comprises residues 16 to 487 as shown in SEQ ID NO:8.
12 . The isolated polypeptide of claim 10 wherein the polypeptide further comprises residues 1 to 487 as shown in SEQ ID NO:8.
13 . An isolated polynucleotide comprising a sequence of nucleotides, wherein the sequence encodes the isolated polypeptide of claim 10 .
14 . An expression vector comprising the following operably linked elements:
a transcription promoter; a DNA segment having the isolated polynucleotide of claim 13 ; and a transcription terminator.
15 . A cultured cell comprising the expression vector of claim 14 .
16 . A method of producing a polypeptide comprising culturing the cell of claim 15 under conditions whereby said sequence of nucleotides is expressed, and recovering said polypeptide.
17 . A polypeptide produced by the method of claim 16 .
18 . An antibody that specifically binds to the isolated protein of claim 10 .
19 . An isolated polynucleotide comprising the polynucleotide sequence as shown in SEQ ID NO:7.
20 . An isolated polypeptide comprising residues 16 to 144 as shown in SEQ ID NO:5.
21 . The isolated polypeptide of claim 20 wherein the polypeptide further comprises residues 1 to 144 as shown in SEQ ID NO:8.
22 . An isolated polynucleotide comprising a sequence of nucleotides, wherein the sequence encodes the isolated polypeptide of claim 20 .
23 . An expression vector comprising the following operably linked elements:
a transcription promoter; a DNA segment having the isolated polynucleotide of claim 22 ; and a transcription terminator.
24 . A cultured cell comprising the expression vector of claim 23 .
25 . A method of producing a polypeptide comprising culturing the cell of claim 24 under conditions whereby said sequence of nucleotides is expressed, and recovering said polypeptide.
26 . A polypeptide produced by the method of claim 25 .
27 . An antibody that specifically binds to the isolated protein of claim 20 .
28 . An isolated polynucleotide comprising the polynucleotide sequence as shown in SEQ ID NO:4.
29 . An isolated polypeptide comprising residues 76 to 363 as shown in SEQ ID NO: 14.
30 . The isolated polypeptide of claim 29 wherein the polypeptide further comprises residues 76 to 663 as shown in SEQ ID NO: 14.
31 . The isolated polypeptide of claim 29 wherein the polypeptide further comprises residues 1 to 663 as shown in SEQ ID NO: 14.
32 . An isolated polynucleotide comprising a sequence of nucleotides, wherein the sequence encodes the isolated polypeptide of claim 29 .
33 . An expression vector comprising the following operably linked elements:
a transcription promoter; a DNA segment having the isolated polynucleotide of claim 32 ; and a transcription terminator.
34 . A cultured cell comprising the expression vector of claim 33 .
35 . A method of producing a polypeptide comprising culturing the cell of claim 34 under conditions whereby said sequence of nucleotides is expressed, and recovering said polypeptide.
36 . A polypeptide produced by the method of claim 35 .
37 . An antibody that specifically binds to the isolated protein of claim 29 .
38 . An isolated polynucleotide comprising the polynucleotide sequence as shown in SEQ ID NO:13.
39 . An isolated polypeptide comprising residues 76 to 278 as shown in SEQ ID NO: 11.
40 . The isolated polypeptide of claim 39 wherein the polypeptide further comprises residues 1 to 278 as shown in SEQ ID NO: 11.
41 . An isolated polynucleotide comprising a sequence of nucleotides, wherein the sequence encodes the isolated polypeptide of claim 39 .
42 . An expression vector comprising the following operably linked elements:
a transcription promoter; a DNA segment having the isolated polynucleotide of claim 39 ; and a transcription terminator.
43 . A cultured cell comprising the expression vector of claim 42 .
44 . A method of producing a polypeptide comprising culturing the cell of claim 43 under conditions whereby said sequence of nucleotides is expressed, and recovering said polypeptide.
45 . A polypeptide produced by the method of claim 44 .
46 . An antibody that specifically binds to the isolated protein of claim 39 .
47 . An isolated polynucleotide comprising the polynucleotide sequence as shown in SEQ ID NO:10.Join the waitlist — get patent alerts
Track US2002076779A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.